Disease/Infection News

RSS

Stem cell therapy shows promise in treating COVID-19 complications

The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.

19 Sep 2023

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.

19 Sep 2023

Hospital wastewater teeming with antibiotic-resistant genes, poses infection risk

Researchers from the UK and the Republic of Ireland have found high levels of antibiotic-resistant genes in the wastewater system of a major teaching hospital. The findings underscore the urgent need for regular decontamination and more stringent infection control measures to protect patients.

19 Sep 2023

Is Facebook's fight against vaccine misinformation failing?

Researchers found that Facebook's policies on removing COVID-19 vaccine misinformation are partially ineffective, as user engagement with anti-vaccine content did not decrease. The study suggests that the platform's system architecture allows users to bypass misinformation-curbing policies, making it challenging to combat the spread effectively.

18 Sep 2023

Bacteriophage cocktail can effectively disrupt Klebsiella pneumoniae biofilms on medical equipment

Researchers investigated whether a cocktail of bacteriophages coding for the depolymerase polysaccharide could effectively disrupt Klebsiella pneumoniae biofilms.

18 Sep 2023

How did exposure to news on COVID-19 through social platforms impact psychological health and behavior?

The relationship between news on the COVID-19 pandemic through social media, feelings of fear and anxiety, and behavior.

18 Sep 2023

COVID-19 pandemic fails to deter osteoporosis treatment initiation: New study reveals steady rates

Whether patients with newly diagnosed osteoporosis received delayed pharmacologic treatment due to the COVID-19 pandemic.

18 Sep 2023

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

The bivalent COVID-19 vaccine developed by GSK and Sanofi shows promising results with a 64.7% overall effectiveness against symptomatic COVID-19, according to a phase 3 trial. The vaccine performs especially well as a booster, achieving 75.9% efficacy in non-naïve subjects.

17 Sep 2023

What's really in your mouthwash? Turkish study spills the minty truth

Researchers review the ingredients and potential health impacts of commercially available mouthwashes in Turkey, revealing a mix of beneficial and potentially harmful components. The study highlights the need for further research on the health effects of mouthwash ingredients, especially given the high incidence of dental disorders in Turkey.

17 Sep 2023

Polish gulls harbor new coronavirus strains, spotlighting avian role in viral evolution

Researchers in Poland have identified five strains of gammacoronaviruses and deltacoronaviruses in black-headed and common gulls, shedding new light on the diversity and evolutionary potential of these viruses. The study highlights the need for ongoing research into animal reservoirs of coronaviruses, as they pose a risk for zoonotic transmission to humans.

17 Sep 2023

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

The study explores the efficacy of three-dose monovalent or bivalent vaccinations in neutralizing newly emerged SARS-CoV-2 variants BA.2.86 and FLip. While BA.2.86 showed lower immune evasion abilities compared to recent XBB variants, it was less effectively neutralized by the monoclonal antibody S309, raising questions about vaccine efficacy against evolving strains.

17 Sep 2023

NIH launches Phase 1 trial of new investigational universal influenza vaccine

Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

15 Sep 2023

Klebsiella: Emerging multidrug-resistant and hypervirulent threats to health

Announcing a new article publication for Zoonoses journal. Members of the genus, Klebsiella, are becoming increasingly challenging to control due to the recent convergence of multidrug-resistant (MDR) and hypervirulent (hv) phenotypes in some species of concern to One Health.

15 Sep 2023

Imported case of monkeypox leads to local transmission in China

Monkeypox (mpox) is a zoonotic disease caused by the mpox virus (MPXV) that has been primarily limited to Central and West African nations since its discovery.

15 Sep 2023

Purdue researcher receives $1.38 million to fight against drug-resistant malaria in developing countries

A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries.

15 Sep 2023

Moderna’s adapted COVID-19 vaccine that targets Omicron XBB.1.5 approved by MHRA

An adapted COVID-19 vaccine from Moderna (Spikevax) that targets the Omicron XBB 1.5 subvariant, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA) after it was found to meet the UK regulator's standards of safety, quality and effectiveness.

15 Sep 2023

A comprehensive analysis of first monkeypox outbreak in Shenzhen, China

This paper comprehensively analyses the first-ever monkeypox outbreak in Shenzhen, China encompassing clinical symptomatology, therapeutic approaches, epidemiological research, and comprehensive laboratory tests, aiming to establish a robust reference for future mitigation and management strategies for monkeypox.

15 Sep 2023

How does Helicobacter pylori infection influence rheumatoid arthritis?

The association between Helicobacter pylori infection and rheumatoid arthritis (RA).

15 Sep 2023

Can upper respiratory tract specimens be used to diagnose Tuberculosis?

The diagnostic accuracy of upper respiratory tract samples for active pulmonary tuberculosis (TB).

15 Sep 2023

A new covid booster is here. Will those at greatest risk get it?

The Centers for Disease Control and Prevention recommends new covid-19 booster vaccines for all — but many who need them most won't get them. About 75% of people in the United States appear to have skipped last year's bivalent booster, and nothing suggests uptake will be better this time around.

15 Sep 2023

Disease/Infection News

Stem cell therapy shows promise in treating COVID-19 complications

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

Hospital wastewater teeming with antibiotic-resistant genes, poses infection risk

Is Facebook's fight against vaccine misinformation failing?

Bacteriophage cocktail can effectively disrupt Klebsiella pneumoniae biofilms on medical equipment

How did exposure to news on COVID-19 through social platforms impact psychological health and behavior?

COVID-19 pandemic fails to deter osteoporosis treatment initiation: New study reveals steady rates

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

What's really in your mouthwash? Turkish study spills the minty truth

Polish gulls harbor new coronavirus strains, spotlighting avian role in viral evolution

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

NIH launches Phase 1 trial of new investigational universal influenza vaccine

Klebsiella: Emerging multidrug-resistant and hypervirulent threats to health

Imported case of monkeypox leads to local transmission in China

Purdue researcher receives $1.38 million to fight against drug-resistant malaria in developing countries

Moderna’s adapted COVID-19 vaccine that targets Omicron XBB.1.5 approved by MHRA

A comprehensive analysis of first monkeypox outbreak in Shenzhen, China

How does Helicobacter pylori infection influence rheumatoid arthritis?

Can upper respiratory tract specimens be used to diagnose Tuberculosis?

A new covid booster is here. Will those at greatest risk get it?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News